TRC105
Showing 26 - 30 of 30
NSCLC Trial in Worldwide (BI 695502, Avastin)
Completed
- Carcinoma, Non-Small-Cell Lung
- BI 695502
- Avastin
-
Anaheim, California
- +188 more
Dec 26, 2019
Diabetic Retinopathy, Chronic Kidney Diseases, Diabetes Trial in Kuala Lumpur (Empagliflozin 25 MG, OCT-A)
Unknown status
- Diabetic Retinopathy
- +2 more
- Empagliflozin 25 MG
- OCT-A
-
Kuala Lumpur, Wilayah Persekutuan, MalaysiaUKM Medical Centre
Dec 29, 2019
Glioblastoma Multiforme Trial run by the NCI (TRC105)
Terminated
- Glioblastoma Multiforme
- TRC105
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 6, 2015
INTRuST Structured Assessment For Evaluation of TBI (SAFE-TBI)
Completed
- Brain Injuries, Traumatic
-
Washington, District of Columbia
- +5 more
Mar 2, 2016
Cancer, Tumor Metastasis Trial in United States (TRC105 chimeric anti-CD105 antibody)
Completed
- Cancer
- Neoplasm Metastasis
- TRC105 chimeric anti-CD105 antibody
-
Scottsdale, Arizona
- +3 more
Mar 2, 2012